Deutsche Bank Aktiengesellschaft Reaffirms Buy Rating for Diploma (LON:DPLM)

Deutsche Bank Aktiengesellschaft reissued their buy rating on shares of Diploma (LON:DPLM) in a research note released on Friday, MarketBeat Ratings reports. They currently have a GBX 5,100 ($64.05) target price on the stock.

Separately, Shore Capital cut Diploma to a “hold” rating in a research report on Tuesday, November 19th.

Diploma Stock Performance

Shares of DPLM stock opened at GBX 4,510 ($56.64) on Friday. The stock has a market capitalization of £6.04 billion, a PE ratio of 5,175.35, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75. Diploma has a 52-week low of GBX 3,200 ($40.19) and a 52-week high of GBX 4,653 ($58.44). The stock’s 50-day moving average price is GBX 4,384.27 and its 200 day moving average price is GBX 4,277.32. The company has a quick ratio of 0.80, a current ratio of 2.27 and a debt-to-equity ratio of 45.69.

Diploma Increases Dividend

The firm also recently announced a dividend, which will be paid on Friday, January 31st. Shareholders of record on Thursday, January 16th will be given a dividend of GBX 42 ($0.53) per share. This is a boost from Diploma’s previous dividend of $17.30. The ex-dividend date is Thursday, January 16th. This represents a yield of 0.93%. Diploma’s payout ratio is presently 6,627.91%.

Insiders Place Their Bets

In other news, insider Johnny Thomson sold 26,794 shares of the business’s stock in a transaction that occurred on Tuesday, November 19th. The stock was sold at an average price of GBX 4,536 ($56.97), for a total transaction of £1,215,375.84 ($1,526,470.54). 0.52% of the stock is currently owned by insiders.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.